United States · FDA National Drug Code directory
Nymalize
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24338-230_217909ac-1821-85a8-e063-6294a90a9e0c
- Product NDC
- 24338-230
- Form
- SOLUTION
- Composition / generic term
- nimodipine
- Labeler
- Azurity Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200504
- Source listing expiry
- 20261231
Source-listed ingredients
- NIMODIPINE — 30 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 PACKAGE in 1 CARTON (24338-230-12) / 1 SYRINGE, PLASTIC in 1 PACKAGE (24338-230-05) / 5 mL in 1 SYRINGE, PLASTIC · 24338-230-12
- 12 BLISTER PACK in 1 CARTON (24338-230-30) / 1 SYRINGE, PLASTIC in 1 BLISTER PACK (24338-230-15) / 5 mL in 1 SYRINGE, PLASTIC · 24338-230-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →